Exane BNP Paribas analyst Kevin Grundy initiated coverage of Procter & Gamble with an Outperform rating and $187 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Rentokil (NYSE:RTO) Soars on Nelson Peltz Stake
- Market Volatility Spikes Amid Conflicting Economic Signals
- Unusually active option classes on open April 30th
- Procter & Gamble Stock (NYSE:PG): Dividend Hikes Don’t Offset Valuation Concerns
- Procter & Gamble price target raised to $185 from $180 at Argus